前收市價 | 1.0300 |
開市 | 1.0100 |
買盤 | 1.0300 x 100 |
賣出價 | 1.0400 x 100 |
今日波幅 | 1.0100 - 1.0400 |
52 週波幅 | 0.8000 - 2.1000 |
成交量 | |
平均成交量 | 1,162,362 |
市值 | 116.995M |
Beta 值 (5 年,每月) | -0.24 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.3200 |
業績公佈日 | 2024年5月09日 - 2024年5月13日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 3.75 |
Gain Therapeutics (GANX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OptiNose (OPTN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OptiNose, Inc. (NASDAQ:OPTN) Q4 2023 Earnings Call Transcript March 7, 2024 OptiNose, Inc. beats earnings expectations. Reported EPS is $-9.0E-5, expectations were $-0.1. OPTN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. […]